CDXS Sep 2024 2.500 put
| Previous Close | 0.3500 |
| Open | 0.3500 |
| Bid | 0.4000 |
| Ask | 0.8000 |
| Strike | 2.50 |
| Expire Date | 2024-09-20 |
| Day's Range | 0.3500 - 0.3500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 55 |
GlobeNewswireCodexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing. Data highlighting this historic manufacturing milestone are being presented today in a Spotlight Presentation at the TIDES USA annual meeting taking place in Boston, MA, and virtually May 14 – 17, 2024. “The data presented today by Codexi
Simply Wall St.Codexis First Quarter 2024 Earnings: Beats Expectations
Codexis ( NASDAQ:CDXS ) First Quarter 2024 Results Key Financial Results Revenue: US$17.1m (up 32% from 1Q 2023). Net...
Insider MonkeyCodexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript
Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript May 2, 2024 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1647, expectations were $-0.17. Codexis, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Codexis’ First Quarter 2024 […]
